Community Trust & Investment’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
Community Trust & Investment's AZN Position: Q2 2026 in Review
Community Trust & Investment reduced its AstraZeneca (AZN) stake by 0.72% in Q2 2026, selling an estimated $125K and leaving 91,081 shares worth $17.3M. The position accounts for 0.89% of the portfolio, ranked #38.
Community Trust & Investment first reported a position in AZN in Q3 2021 and has held it in 20 quarters since. The position peaked at $20.6M in Q4 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Community Trust & Investment held 91,081 shares of AstraZeneca worth $17.3M as of Q2 2026.
- Community Trust & Investment sold 662 AstraZeneca shares in Q2 2026, an estimated $125K.
- AstraZeneca made up 0.89% of Community Trust & Investment's portfolio in Q2 2026, its #38 holding.
- Community Trust & Investment first reported a position in AstraZeneca in Q3 2021 and has held it in 20 quarters since.
- Community Trust & Investment's AstraZeneca position peaked at $20.6M in Q4 2025.
- 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Community Trust & Investment's 13F filing for Q2 2026, filed 8 Jul 2026.